iScience (Nov 2021)

IL-17A reprograms intestinal epithelial cells to facilitate HIV-1 replication and outgrowth in CD4+ T cells

  • Tomas Raul Wiche Salinas,
  • Annie Gosselin,
  • Laurence Raymond Marchand,
  • Etiene Moreira Gabriel,
  • Olivier Tastet,
  • Jean-Philippe Goulet,
  • Yuwei Zhang,
  • Dragos Vlad,
  • Hanane Touil,
  • Jean-Pierre Routy,
  • Mariana G. Bego,
  • Mohamed El-Far,
  • Nicolas Chomont,
  • Alan L. Landay,
  • Éric A. Cohen,
  • Cécile Tremblay,
  • Petronela Ancuta

Journal volume & issue
Vol. 24, no. 11
p. 103225

Abstract

Read online

Summary: The crosstalk between intestinal epithelial cells (IECs) and Th17-polarized CD4+ T cells is critical for mucosal homeostasis, with HIV-1 causing significant alterations in people living with HIV (PLWH) despite antiretroviral therapy (ART). In a model of IEC and T cell co-cultures, we investigated the effects of IL-17A, the Th17 hallmark cytokine, on IEC ability to promote de novo HIV infection and viral reservoir reactivation. Our results demonstrate that IL-17A acts in synergy with TNF to boost IEC production of CCL20, a Th17-attractant chemokine, and promote HIV trans-infection of CD4+ T cells and viral outgrowth from reservoir cells of ART-treated PLWH. Importantly, the Illumina RNA-sequencing revealed an IL-17A-mediated pro-inflammatory and pro-viral molecular signature, including a decreased expression of type I interferon (IFN-I)-induced HIV restriction factors. These findings point to the deleterious features of IL-17A and raise awareness for caution when designing therapies aimed at restoring the paucity of mucosal Th17 cells in ART-treated PLWH.

Keywords